TY  - JOUR

T1  - Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro

JO  - Proceedings of the National Academy of Sciences

PY  - 1999/01/05

AU  - Fisher JE

AU  - Rogers MJ

AU  - Halasy JM

AU  - Luckman SP

AU  - Hughes DE

AU  - Masarachia PJ

AU  - Wesolowski G

AU  - Russell RGG

AU  - Rodan GA

AU  - Reszka AA

ED  - 

DO  - DOI: 10.1073/pnas.96.1.133

PB  - Proceedings of the National Academy of Sciences

VL  - 96

IS  - 1

SP  - 133

EP  - 138

Y2  - 2025/10/10

ER  -